Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 4
2006 1
2007 3
2008 11
2009 5
2010 9
2011 3
2012 6
2013 7
2014 6
2015 10
2016 14
2017 15
2018 9
2019 9
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 32253276

100 results
Results by year
Filters applied: . Clear all
Page 1
Benefits of Continuing RAAS Inhibitors in Advanced CKD.
Gaudreault-Tremblay MM, Foster BJ. Gaudreault-Tremblay MM, et al. Clin J Am Soc Nephrol. 2020 May 7;15(5):592-593. doi: 10.2215/CJN.02920320. Epub 2020 Apr 6. Clin J Am Soc Nephrol. 2020. PMID: 32253276 Free PMC article. No abstract available.
Effects of RAAS Inhibitors in Patients with Kidney Disease.
Zhang F, Liu H, Liu D, Liu Y, Li H, Tan X, Liu F, Peng Y, Zhang H. Zhang F, et al. Curr Hypertens Rep. 2017 Aug 8;19(9):72. doi: 10.1007/s11906-017-0771-9. Curr Hypertens Rep. 2017. PMID: 28791529 Review.
The effect of renin-angiotensin-aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design.
García-Prieto AM, Verdalles Ú, de José AP, Verde E, Arroyo D, Aragoncillo I, Linares T, Barbieri D, Goicoechea M. García-Prieto AM, et al. Hipertens Riesgo Vasc. 2020 Jul-Sep;37(3):101-107. doi: 10.1016/j.hipert.2020.02.005. Epub 2020 Mar 8. Hipertens Riesgo Vasc. 2020. PMID: 32156479 Clinical Trial.
100 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page